Kinomic profiling approach identifies Trk as a novel radiation modulator

John S. Jarboe, Jerry Jaboin, Joshua C. Anderson, Somaira Nowsheen, Jennifer A. Stanley, Faris Naji, Rob Ruijtenbeek, Tianxiang Tu, Dennis E. Hallahan, Eddy S. Yang, James A. Bonner, Christopher D. Willey

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Background: Ionizing radiation treatment is used in over half of all cancer patients, thus determining the mechanisms of response or resistance is critical for the development of novel treatment approaches. Materials and methods: In this report, we utilize a high-content peptide array platform that performs multiplex kinase assays with real-time kinetic readout to investigate the mechanism of radiation response in vascular endothelial cells. We applied this technology to irradiated human umbilical vein endothelial cells (HUVEC). Results: We identified 49 specific tyrosine phosphopeptides that were differentially affected by irradiation over a time course of 1 h. In one example, the Tropomyosin receptor kinase (Trk) family members, TrkA and TrkB, showed transient activation between 2 and 15 min following irradiation. When we targeted TrkA and TrkB using small molecule inhibitors, HUVEC were protected from radiation damage. Conversely, stimulation of TrkA using gambogic amide promoted radiation enhancement. Conclusions: Thus, we show that our approach not only can identify rapid changes in kinase activity but also identify novel targets such as TrkA. TrkA inhibition resulted in radioprotection that correlated with enhanced repair of radiation-induced damage while TrkA stimulation by gambogic amide produced radiation sensitization.

Original languageEnglish (US)
Pages (from-to)380-387
Number of pages8
JournalRadiotherapy and Oncology
Volume103
Issue number3
DOIs
StatePublished - Jun 2012
Externally publishedYes

Fingerprint

Radiation
Human Umbilical Vein Endothelial Cells
Phosphotransferases
Background Radiation
Phosphopeptides
Ionizing Radiation
Tyrosine
Endothelial Cells
tropomyosin kinase
Technology
Peptides
Therapeutics
Neoplasms
gambogic amide

Keywords

  • DNA repair
  • Kinomics
  • Radiation
  • Trk
  • Tumor microvasculature

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Hematology

Cite this

Jarboe, J. S., Jaboin, J., Anderson, J. C., Nowsheen, S., Stanley, J. A., Naji, F., ... Willey, C. D. (2012). Kinomic profiling approach identifies Trk as a novel radiation modulator. Radiotherapy and Oncology, 103(3), 380-387. https://doi.org/10.1016/j.radonc.2012.03.014

Kinomic profiling approach identifies Trk as a novel radiation modulator. / Jarboe, John S.; Jaboin, Jerry; Anderson, Joshua C.; Nowsheen, Somaira; Stanley, Jennifer A.; Naji, Faris; Ruijtenbeek, Rob; Tu, Tianxiang; Hallahan, Dennis E.; Yang, Eddy S.; Bonner, James A.; Willey, Christopher D.

In: Radiotherapy and Oncology, Vol. 103, No. 3, 06.2012, p. 380-387.

Research output: Contribution to journalArticle

Jarboe, JS, Jaboin, J, Anderson, JC, Nowsheen, S, Stanley, JA, Naji, F, Ruijtenbeek, R, Tu, T, Hallahan, DE, Yang, ES, Bonner, JA & Willey, CD 2012, 'Kinomic profiling approach identifies Trk as a novel radiation modulator', Radiotherapy and Oncology, vol. 103, no. 3, pp. 380-387. https://doi.org/10.1016/j.radonc.2012.03.014
Jarboe, John S. ; Jaboin, Jerry ; Anderson, Joshua C. ; Nowsheen, Somaira ; Stanley, Jennifer A. ; Naji, Faris ; Ruijtenbeek, Rob ; Tu, Tianxiang ; Hallahan, Dennis E. ; Yang, Eddy S. ; Bonner, James A. ; Willey, Christopher D. / Kinomic profiling approach identifies Trk as a novel radiation modulator. In: Radiotherapy and Oncology. 2012 ; Vol. 103, No. 3. pp. 380-387.
@article{8d94a6584921450fae25b0561eb4bcc6,
title = "Kinomic profiling approach identifies Trk as a novel radiation modulator",
abstract = "Background: Ionizing radiation treatment is used in over half of all cancer patients, thus determining the mechanisms of response or resistance is critical for the development of novel treatment approaches. Materials and methods: In this report, we utilize a high-content peptide array platform that performs multiplex kinase assays with real-time kinetic readout to investigate the mechanism of radiation response in vascular endothelial cells. We applied this technology to irradiated human umbilical vein endothelial cells (HUVEC). Results: We identified 49 specific tyrosine phosphopeptides that were differentially affected by irradiation over a time course of 1 h. In one example, the Tropomyosin receptor kinase (Trk) family members, TrkA and TrkB, showed transient activation between 2 and 15 min following irradiation. When we targeted TrkA and TrkB using small molecule inhibitors, HUVEC were protected from radiation damage. Conversely, stimulation of TrkA using gambogic amide promoted radiation enhancement. Conclusions: Thus, we show that our approach not only can identify rapid changes in kinase activity but also identify novel targets such as TrkA. TrkA inhibition resulted in radioprotection that correlated with enhanced repair of radiation-induced damage while TrkA stimulation by gambogic amide produced radiation sensitization.",
keywords = "DNA repair, Kinomics, Radiation, Trk, Tumor microvasculature",
author = "Jarboe, {John S.} and Jerry Jaboin and Anderson, {Joshua C.} and Somaira Nowsheen and Stanley, {Jennifer A.} and Faris Naji and Rob Ruijtenbeek and Tianxiang Tu and Hallahan, {Dennis E.} and Yang, {Eddy S.} and Bonner, {James A.} and Willey, {Christopher D.}",
year = "2012",
month = "6",
doi = "10.1016/j.radonc.2012.03.014",
language = "English (US)",
volume = "103",
pages = "380--387",
journal = "Radiotherapy and Oncology",
issn = "0167-8140",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Kinomic profiling approach identifies Trk as a novel radiation modulator

AU - Jarboe, John S.

AU - Jaboin, Jerry

AU - Anderson, Joshua C.

AU - Nowsheen, Somaira

AU - Stanley, Jennifer A.

AU - Naji, Faris

AU - Ruijtenbeek, Rob

AU - Tu, Tianxiang

AU - Hallahan, Dennis E.

AU - Yang, Eddy S.

AU - Bonner, James A.

AU - Willey, Christopher D.

PY - 2012/6

Y1 - 2012/6

N2 - Background: Ionizing radiation treatment is used in over half of all cancer patients, thus determining the mechanisms of response or resistance is critical for the development of novel treatment approaches. Materials and methods: In this report, we utilize a high-content peptide array platform that performs multiplex kinase assays with real-time kinetic readout to investigate the mechanism of radiation response in vascular endothelial cells. We applied this technology to irradiated human umbilical vein endothelial cells (HUVEC). Results: We identified 49 specific tyrosine phosphopeptides that were differentially affected by irradiation over a time course of 1 h. In one example, the Tropomyosin receptor kinase (Trk) family members, TrkA and TrkB, showed transient activation between 2 and 15 min following irradiation. When we targeted TrkA and TrkB using small molecule inhibitors, HUVEC were protected from radiation damage. Conversely, stimulation of TrkA using gambogic amide promoted radiation enhancement. Conclusions: Thus, we show that our approach not only can identify rapid changes in kinase activity but also identify novel targets such as TrkA. TrkA inhibition resulted in radioprotection that correlated with enhanced repair of radiation-induced damage while TrkA stimulation by gambogic amide produced radiation sensitization.

AB - Background: Ionizing radiation treatment is used in over half of all cancer patients, thus determining the mechanisms of response or resistance is critical for the development of novel treatment approaches. Materials and methods: In this report, we utilize a high-content peptide array platform that performs multiplex kinase assays with real-time kinetic readout to investigate the mechanism of radiation response in vascular endothelial cells. We applied this technology to irradiated human umbilical vein endothelial cells (HUVEC). Results: We identified 49 specific tyrosine phosphopeptides that were differentially affected by irradiation over a time course of 1 h. In one example, the Tropomyosin receptor kinase (Trk) family members, TrkA and TrkB, showed transient activation between 2 and 15 min following irradiation. When we targeted TrkA and TrkB using small molecule inhibitors, HUVEC were protected from radiation damage. Conversely, stimulation of TrkA using gambogic amide promoted radiation enhancement. Conclusions: Thus, we show that our approach not only can identify rapid changes in kinase activity but also identify novel targets such as TrkA. TrkA inhibition resulted in radioprotection that correlated with enhanced repair of radiation-induced damage while TrkA stimulation by gambogic amide produced radiation sensitization.

KW - DNA repair

KW - Kinomics

KW - Radiation

KW - Trk

KW - Tumor microvasculature

UR - http://www.scopus.com/inward/record.url?scp=84861795925&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861795925&partnerID=8YFLogxK

U2 - 10.1016/j.radonc.2012.03.014

DO - 10.1016/j.radonc.2012.03.014

M3 - Article

VL - 103

SP - 380

EP - 387

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

SN - 0167-8140

IS - 3

ER -